Continuous Glucose Monitoring in the Intensive Care Unit

Diabetes Mellitus Clinical Trial

Official title: Continuous Glucose Monitoring in the Intensive Care Unit: Validation and Implementation

Status Not yet recruiting

Clinical Trial Summary

The aim of the proposed clinical trial is to study the use of the Dexcom G7 continuous glucose monitor (CGM) within the intensive care unit (ICU) environment. The overall goal is to validate the accuracy and practicality of the Dexcom G7 when used to assess glycemia in critically ill patients.

Clinical Trial Description

The specific goals are 1) to work with intensive care unit (ICU) staff, in a respiratory ICU setting, to determine how best to place and maintain Dexcom G7 continuous glucose monitors (CGMs) on patients and how to place recording devices and chargers in that environment, 2) download CGM readings to the Dexcom Dashboard in an analyzable format, and 3) to compare simultaneous CGM readings with glucose measurements obtained in the course of routine care as recorded in the electronic medical record. The primary analytical goal is the correlation of CGM glucose measurements with those obtained in the course of routine care. A secondary goal is to determine the frequency of device malfunctions that occur either as a result of device failure (e.g. it falls off) or adverse events (e.g. removal due to skin irritation).

Study subjects will be patients admitted to the 6-ICU UMass Memorial Medical Center (UMMMC) University Campus medical intensive care unit for any reason who have known diabetes or who are hyperglycemic (blood glucose concentration ≥200 mg/dL) with diabetes that was previously undiagnosed or unrecognized. All enrolled volunteers will have a Dexcom G7 CGM place on the skin according to manufacturer's specifications. The devices will remain in place for 10 days or until discharge from the ICU ;

Related Conditions & MeSH terms

• Diabetes Mellitus

• NCT number: NCT06190808
• Study type: Interventional
• Source: University of Massachusetts, Worcester
• Contact: John P Mordes, MD
• Phone: 6178884488
• Email: john.mordes@umassmed.edu
• Status: Not yet recruiting
• Phase: N/A
• Start date: January 2, 2024
• Completion date: June 30, 2024